Although there are risks associated with PSA screening such as an unnecessary biopsy or undue mental distress due to a baseline elevated PSA, data suggest that routine screening decreases mortality rates and should be encouraged for those considered at high risk, (i.e. Black men) or those with a family history of prostate cancer [14]. The gene discussed is KLK3; the disease is Familial prostate cancer.